News
Nyxoah (Nasdaq:NYXH) announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.
NanoVibronix (Nasdaq:NAOV) today announced that it intends to effect a reverse stock split of its common stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback